- Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on May 23
- Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements
- Nexalin Technology Accelerates Manufacturing of its HALO™ Clarity Following Successful Usability, Feasibility, and Electrical Testing
- Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device
- Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board
- Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego
- Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin’s Technology
- Nexalin Technology Announces Poster Presentation at “State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment”
- Nexalin Technology Announces Positive Results from Clinical Study of its Gen-2 tACS Device for Treating Adult Patients with Chronic Insomnia
- Nexalin Technology Announces Regulatory Approval in Oman for Gen-2 Neurostimulation Device
More ▼
Key statistics
On Friday, Nexalin Technology Inc (NXL:NAQ) closed at 1.28, 406.33% above the 52 week low of 0.2528 set on Feb 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.19 |
---|---|
High | 1.32 |
Low | 1.19 |
Bid | 1.24 |
Offer | 1.32 |
Previous close | 1.16 |
Average volume | 89.60k |
---|---|
Shares outstanding | 7.44m |
Free float | 5.73m |
P/E (TTM) | -- |
Market cap | 9.52m USD |
EPS (TTM) | -0.6303 USD |
Data delayed at least 15 minutes, as of May 10 2024 20:59 BST.
More ▼